Results 71 to 80 of about 71,298 (290)

Pediatric IBD patients show medication and disease activity dependent changes in NK cell and CD4 memory T cell populations

open access: yesFrontiers in Pediatrics, 2023
ObjectivesCD4+ memory T cells facilitate long-termed adaptive immune responses while NK cells are predominately rapid effector cells with significant functions for both intestinal homeostasis and inflammation.
Angeliki Pappa   +8 more
doaj   +1 more source

Guidelines for prescribing azathioprine in dermatology

open access: yes, 2004
Azathioprine has been available as an immunosuppressive agent for over 40 years, and current routine usage in dermatology is not restricted to licensed indications.
N.J. REYNOLDS   +5 more
core   +1 more source

Posterior Reversible Encephalopathy Syndrome and Azathioprine [PDF]

open access: yes, 2019
Posterior reversible encephalopathy syndrome (PRES) is a rare syndrome that presents with neurological manifestations, often associated with arterial hypertension.
Sara Pinto Teixeira Vilas-Boas   +3 more
core   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

open access: yesArthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper   +7 more
wiley   +1 more source

Azathioprine-induced Acute Cholestatic Hepatitis in a Patient with Systemic Lupus Erythematosus: A Case Report

open access: yesJournal of Medical Sciences
Azathioprine is commonly used in organ transplantation and for the treatment of autoimmune diseases. The common side effects are gastrointestinal symptoms, bone marrow suppression, skin reactions, and hepatitis with elevated liver enzymes. We presented a
Wei-Luen Yen   +3 more
doaj   +1 more source

Comparative study of safety and efficacy of oral betamethasone pulse therapy and azathioprine in vitiligo

open access: yesClinical Dermatology Review, 2019
Background: Vitiligo is a common skin disorder causing depigmented macules that can impair a patient's quality of life. There are number of treatment modalities are available but at the present, there are no studies compairing betamethasone pulse therapy
Mahajabeen Madarkar   +2 more
doaj   +1 more source

Azathioprine for multiple sclerosis

open access: yes, 2009
Background: Azathioprine (AZA) is an immunosuppressive drug widely prescribed for the treatment of multiple sclerosis (MS) until the first half of the 1990s. It could be an alternative to interferon β because it is less expensive.
Iuliano G, Filippini G., CASETTA, Ilaria
core   +1 more source

Azathioprine in the management of autoimmune uveitis [PDF]

open access: yes, 2008
Purpose: To evaluate the role of azathioprine as an immunosuppressive for steroid-resistant autoimmune uveitis (AIU). Methods: Patients using oral prednisolone for active AIU without clinical response were recruited.
Taylor, Simon R.J.   +3 more
core   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns   +2 more
wiley   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

open access: yesArthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

Home - About - Disclaimer - Privacy